US FDA approves Mounjaro to reduce cardiovascular risk ...Middle East

The News - Cultural
US FDA approves Mounjaro to reduce cardiovascular risk
The FDA has officially approved its diabetes drug Lilly’s Mounjaro to prevent a heart attack or stroke in adults with type 2 diabetes who are at high risk of cardiovascular events on Friday.Mounjaro is the primary drug that targets the GLP-1 protein and is also used for weight loss....

Hence then, the article about us fda approves mounjaro to reduce cardiovascular risk was published today ( ) and is available on The News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US FDA approves Mounjaro to reduce cardiovascular risk )

Apple Storegoogle play

Last updated :

Also on site :



Latest News